Clinical Trial Update: Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating trastuzumab with or without everolimus in women with surgically removable breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED